In8Bio (INAB) Current Leases (2021 - 2026)
In8Bio's (INAB) quarterly Current Leases came in at $923000.0 in Q2 2026, up 72.2% year-over-year from $536000.0 in Q2 2025, and up 10.01% quarter-over-quarter from $839000.0 in Q1 2026.
Powered by 
Analysis
In8Bio (INAB) Current Leases (2021 - 2026) Analysis & Trends
In8Bio has disclosed Current Leases across 6 years of filings, most recently posting $923000.0 for Q2 2026.
- In Q2 2026, Current Leases rose 72.2% year-over-year to $923000.0; the TTM figure through Jun 2026 stood at $923000.0 (up 72.2% YoY), while the FY2025 annual figure was $924000.0, down 3.04% from the prior year.
- Current Leases came in at $923000.0 for Q2 2026 at In8Bio, up from $839000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $953000.0 in Q4 2024 to a low of $299000.0 in Q2 2022.
- Average Current Leases over 5 years is $739722.2, with a median of $774000.0 recorded in 2023.
- Year-over-year, Current Leases sank 42.17% in 2022 and surged 155.85% in 2023.
- Over 5 years, Current Leases stood at $707000.0 in 2022, then climbed by 15.98% to $820000.0 in 2023, then rose by 16.22% to $953000.0 in 2024, then decreased by 3.04% to $924000.0 in 2025, then retreated by 0.11% to $923000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $923000.0 in Q2 2026, $839000.0 in Q1 2026, and $924000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 1.81 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 18.65 Mn |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 2.67 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 2.99 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 15.21 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 1.06 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 14.16 Mn |
| 10 | In8Bio | 21.25 Mn | 21.25 Mn | - | 923,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 923,000.00 |
| Mar 31, 2026 | 839,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 738,000.00 |
| Jun 30, 2025 | 536,000.00 |
| Mar 31, 2025 | 661,000.00 |
| Dec 31, 2024 | 953,000.00 |
| Sep 30, 2024 | 920,000.00 |
| Jun 30, 2024 | 895,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Sep 30, 2023 | 783,000.00 |
| Jun 30, 2023 | 765,000.00 |
| Mar 31, 2023 | 732,000.00 |
| Dec 31, 2022 | 707,000.00 |
| Sep 30, 2022 | 639,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 392,000.00 |
| Sep 30, 2021 | 464,000.00 |